Oral-health quality of life and treatment patterns in people with new dentin hypersensitivity
Official title: A Longitudinal Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers in the Real World
Run by Haleon · NCT07337109 · Data updated 2026-11-12
This study will test whether monthly online questionnaires over a year can track changes in oral-health-related quality of life and treatment use in adults who recently began having dentin hypersensitivity.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 375 (estimated) |
| Sponsor | Haleon Industry-sponsored |
| Locations | 1 site (Las Vegas, Nevada) |
| Status | Recruiting |
| Started | December 16, 2025 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT07337109 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) living in the United States who self-identify as having started experiencing dentin hypersensitivity within the past three months, who have begun using sensitivity treatments within the past three months, and who can complete monthly online surveys are ideal candidates.
✕Probably not a fit
People with chronic health conditions that affect participation, those whose tooth sensitivity is due to other dental pathologies, those with longstanding sensitivity (>3 months), or those living outside the United States are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a 12-month longitudinal observational study enrolling 375 adults in the United States who self-report new-onset dentin hypersensitivity within the past three months. Participants will complete a monthly online battery including the Dentin Hypersensitivity Experience Questionnaire (DHEQ) to measure oral-health-related quality of life and report treatments they use. No experimental interventions are given; the study records treatment patterns and symptom trajectories in a real-world setting. Data will be used to describe how quality of life changes over time and which consumer or clinical products are adopted.
Why it matters
Potential benefit: If successful, findings could help dentists, manufacturers, and patients understand how sensitivity affects daily life and which common treatments actually correlate with improved quality of life.
How similar studies have gone: Previous observational work using patient-reported measures like the DHEQ has described the burden of dentin hypersensitivity, although monthly longitudinal tracking over a full year is less common.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant who has provided consent indicating they have been informed of all pertinent aspects of the study. * All genders who, at the time of screening, are aged more than or equal to (\>=)18 years. * Anyone who has begun to experience dentin hypersensitivity (self-reported) within the past three months. * Anyone who has started to use products to treat their tooth sensitivity within the past three months. * Participant who is able to independently complete all activities online. * Participants residing in the United States. Exclusion Criteria: * Anyone who has any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period. * Participant whose sensitivity could be caused by other factors or clinical pathology than DH, as self-reported on the screening questionnaire, which include: 1. Anyone who suffers from tooth cavities, significant gum disease, cracked or fractured teeth, temporomandibular joint disease (TMD), or who has had tooth extractions or fillings within the last three months. 2. Anyone who wears braces (including Invisalign-like appliances) for treatment or dentures (full or partial). 3. Participant who has undergone treatment for periodontal or gum disease within 6 months of screening or is currently undergoing treatment for periodontal or gum disease. 4. Participant who has been informed by a Dental Health Care Professional (DHCP) that they have active periodontitis. 5. Participant who has been informed by a DHCP that they have active caries. 6. Participant with any chronic and/or severe painful health condition(s) which lead to regular use of pain relief medications (more than 3 days a week). * Anyone who has participated in another dentin hypersensitivity study within the last three months. * Currently participating in another research study or will be participating in any other research study at any point during this study's duration.
Where it's running
-
Citruslabs (Virtual Site)
Las Vegas, Nevada, United States Recruiting
Study contacts
- Study coordinator: Haleon Response Center
- Email: ww.clinical-trial-register@haleon.com
- Phone: +441932959500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two varnishes for dentin hypersensitivity: fluoride-containing vs fluoride-free
This study tests whether a fluoride-containing dental varnish reduces dentin hypersensitivity more than a fluoride-free varnish in adults with non-carious, vital teeth.
-
Tooth wear and sensitivity and their risk factors across U.S. dental school sites
This study will see how common tooth wear and tooth sensitivity are in U.S. adults and what factors are linked to them.
-
Hydroxyapatite home treatment for sensitive teeth in people with celiac disease
The trial will see if adding a nightly hydroxyapatite mousse to regular hydroxyapatite toothpaste reduces tooth sensitivity in adults with celiac disease and enamel demineralization.
-
Comparing two mouthwashes for treating dentinal hypersensitivity
This study is testing which mouthwash works better to relieve tooth sensitivity in people who have it.
-
Comparing Clinpro Clear and Duraphat varnishes for dentin hypersensitivity in young adults
This test will see if a single application of Clinpro Clear or Duraphat reduces dentin hypersensitivity in adults aged 18–40.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.